Clinical Trial Update: A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating PF-07220060 in combination with PF-07104091 for breast cancer and solid tumors. The study is currently ACTIVE_NOT_RECRUITING…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• PF-07104091
• PF-07220060

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer, Solid Tumors | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING